Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)
STROKAO
1 other identifier
observational
91
1 country
1
Brief Summary
The eye has long been recognized as a window to pathological processes occurring in the brain. By imaging the vascular system of the retina scientific understanding and clinical practice have been improved for a wide range of pathologies from diabetes to stroke and dementia. Adaptive optics (AO) reveals retinal details that remain invisible with other current imaging techniques. Indeed, vessels can be perfectly visualized, making it possible to detect wall irregularities, accurately measure their different structures and monitor their evolution under treatment if necessary. In AO, studies on retinal vessels involve the calculation of wall thickness (WT), outer diameter (OD), inner diameter (ID), wall cross-sectional area (WCSA) and wall to lumen ratio (WLR). An increase in WLR \> 0.31 is characteristic of hypertensive microangiopathy and predictive of cardiovascular and brain damage. This accurate assessment of microvascular structure may even be required in the near future in all patients with arterial hypertension. For vessels \> 300 microns in diameter, the increase in vessel wall thickness occurs without changing the ID, a process known as external hypertrophic remodeling. For small arteries \< 300 microns, remodeling occurs differently. The total volume of the vessel wall remains constant, but the OD and ID each decrease, a process known as inward eutrophic remodeling. The objective of this study is to describe the parameters measured in AO in patients in the acute phase of a stroke and then at 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2021
CompletedFirst Posted
Study publicly available on registry
January 15, 2021
CompletedStudy Start
First participant enrolled
January 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2025
CompletedDecember 10, 2025
December 1, 2025
4 years
January 14, 2021
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Wall thickness (WT) in adaptive optics
Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls
At the inclusion visit (less than 10 days after the stroke for the patients with stroke)
Wall cross-sectional area (WCSA) in adaptive optics
Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls
At the inclusion visit (less than 10 days after the stroke for the patients with stroke)
Wall to lumen ratio (WLR) in adaptive optics
Comparison between groups : hemorrhagic strokes, ischemic strokes, controls
At the inclusion visit (less than 10 days after the stroke for the patients with stroke)
Study Arms (2)
Cases - patients with stroke
Ophthalmological examinations : At the inclusion visit and 3 months after their stroke Blood pressure measurement at rest : At the inclusion visit
Controls - Individuals with no history of stroke
Ophthalmological examinations : At the inclusion visit Blood pressure measurement at rest : At the inclusion visit
Interventions
* OCT (Optical Coherence Tomography): posterior pole OCT B scan , optic nerve and posterior pole OCT Angiography * Adaptive optics (AO) : Image acquisition on the vessels at the exit of the optic nerve before the first upper temporal bifurcation OD or OG and evaluation of the photoreceptor mosaic. Adaptive optics may require dilatation of the pupil with a drop of tropicamide in the eye examined a few minutes before the examination. * Color retinophotography * Measurement of intraocular pressure Patients with stroke : At the inclusion visit and 3 months after their stroke Control group : At the inclusion visit.
At the inclusion visit
Eligibility Criteria
Inpatients with confirmed stroke for less than 10 days and controls (Individuals presenting at the Rothschild Foundation Hospital with no history of stroke)
You may qualify if:
- For the patients with stroke: Inpatients with confirmed stroke (clinical and imaging) for less than 10 days
- For the controls: Individuals presenting at the Rothschild Foundation Hospital with no history of stroke who are matched to cases already included in the matching criteria: Age ± 5 years, Gender, high blood pressure (no history, untreated, treated) Diabetes (Yes, No), Body Mass Index (BMI \< 25, 25 ≥ BMI \< 30, BMI ≥ 30)
You may not qualify if:
- Pregnant or breastfeeding woman
- Insufficient state of consciousness or physical condition to perform the adaptive optics examination
- For the patients with stroke: Hemorrhagic post-traumatic hematoma stroke type, or symptomatic stroke of a brain tumour or an arteriovenous malformation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Fondation A. de Rothschuld
Paris, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martine MAUGET FAYSSE, MD
Hôpital Fondation A. de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2021
First Posted
January 15, 2021
Study Start
January 25, 2021
Primary Completion
January 14, 2025
Study Completion
January 14, 2025
Last Updated
December 10, 2025
Record last verified: 2025-12